Source:http://linkedlifedata.com/resource/pubmed/id/12243501
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0000854,
umls-concept:C0010592,
umls-concept:C0022646,
umls-concept:C0030705,
umls-concept:C0035015,
umls-concept:C0181904,
umls-concept:C0205411,
umls-concept:C0332157,
umls-concept:C0450127,
umls-concept:C0596972,
umls-concept:C0728873,
umls-concept:C1511545,
umls-concept:C1521743,
umls-concept:C1548437,
umls-concept:C1704646,
umls-concept:C1882923,
umls-concept:C2003903
|
pubmed:issue |
8
|
pubmed:dateCreated |
2002-9-23
|
pubmed:abstractText |
This study used receiver operating characteristic analysis to investigate the properties of area under the concentration-time curve during the first 4h after cyclosporin-microemulsion dosing (AUC0-4) and cyclosporin (CyA) levels immediately before and at 2 and 3h after dosing (C0, C2 and C3) to predict the risk of biopsy-proven acute rejection (AR) at 6 months. Ninety-eight kidney transplant recipients treated with CyA-microemulsion-based triple therapy immunosuppression were studied on post-transplant days 3, 5, and 7, and at increasing intervals thereafter. The most sensitive and specific predictor of AR was AUC0-4. Of the single time-point measurements, the measurement properties of C2 were closest to those of AUC0-4, and superior to those of C3. The relationship between C0 and subsequent AR was weak and did not reach statistical significance. On day 3, CyA AUC0-4 > or = 4,400 ng.h/mL and C2 > or = 1,700 ng/mL were each associated with a 92% negative predictive value for rejection in the first 6months. Pharmacokinetic measurements on or after day 5, and measurements on day 3 in patients with delayed graft function, were not predictive of AR. Adequate exposure within the first 3days post transplantation may be critically important in preventing subsequent rejection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1600-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
789-95
|
pubmed:dateRevised |
2007-2-14
|
pubmed:meshHeading |
pubmed-meshheading:12243501-Adult,
pubmed-meshheading:12243501-Cyclosporine,
pubmed-meshheading:12243501-Female,
pubmed-meshheading:12243501-Graft Rejection,
pubmed-meshheading:12243501-Humans,
pubmed-meshheading:12243501-Immunosuppressive Agents,
pubmed-meshheading:12243501-Kidney Transplantation,
pubmed-meshheading:12243501-Male,
pubmed-meshheading:12243501-ROC Curve,
pubmed-meshheading:12243501-Time Factors,
pubmed-meshheading:12243501-Transplantation, Homologous
|
pubmed:year |
2002
|
pubmed:articleTitle |
Adequate early cyclosporin exposure is critical to prevent renal allograft rejection: patients monitored by absorption profiling.
|
pubmed:affiliation |
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
|
pubmed:publicationType |
Journal Article
|